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628a Wednesday, February 6, 2013inhibition in ClC-7 function. Leisle L, Ludwig CF, et. al recently utilized
a method to robustly redirect ClC-7 to the plasma membrane by mutating lyso-
somal sorting motifs at the amino terminus of ClC-7 and by co-expressing an
essential auxiliary subunit called Ostm-1 (Leisle, Ludwig, et al, 2011 EMBO
J, 30,2140). using this strategy, we describe extracellular [Hþ]-dependent inhi-
bition of ClC-7 mediated ionic current in comparison with published data for
ClC-5 from experiments by Picollo, Malvezzi, and Accardi (2010, JGP, 135,
653). In the tested conditions, ClC-7 is more sensitive than ClC-5 to extracel-
lular Hþ (pK(0 mV) = 7.9 estimated for ClC-7/Ostm-1 and pK(0 mV) = 6.6
reported for ClC-5 expressed in oocytes). Further, we evaluate effects of
increasing extracellular [Hþ] and varying intracellular [Cl] on voltage-
dependent transient current intrinsic to a transport deficient mutant of ClC-7
(E314A). Increasing [Hþ]ext shifts the half-activating voltage of voltage-
dependent charge movement in ClC-7 (mean V1/2 R þ20 mV shift per pH
unit increase), but does not drastically change the apparent charge valence
(mean z = 0.85 to 0.95 qe at all [H
þ]ext tested). This result suggests that the
voltage-dependent transient current does not arise from protonation of ClC-7,
but that extracellular pH changes the work required for the electric field to elicit
charge movement.
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Recently we have shown that GlialCAM, a cell adhesion molecule expressed
mainly in glia, is a CLC-2 chloride channel subunit (1). Co-expression of
CLC-2withGlialCAM leads to a dramatic activation of currents and to a cluster-
ing ofCLC-2 at cell contacts (1). Herewe present an analysis of the interaction of
GlialCAMwith CLC-0 and CLC-1, two other CLC channels. CLC-1 biochemi-
cally interacts with GlialCAM and GlialCAM induces clustering of CLC-1 at
cell contacts. Currents of CLC-1 and CLC-0 are modified by GlialCAM, but
our study was focused mainly on CLC-0 because here slow and fast gating
can be more easily separated. In particular, co-expression with GlialCAM led
to an increase of the residual open-probability of the slow gate at positive
voltages and the block by Zinc, which is mediated by affecting the slow gate
(2) was largely reduced. In addition, deactivation of the slow gate was dramati-
cally slowed, but retained the typical large temperature dependence (3). The
mutant C212S, which lacks slow gating transitions (4), was not affected by
co-expression with GlialCAM. Thus, GlialCAM is able to interact with CLC
channels different from CLC-2. Our results show that in the context of CLC-0,
the interaction with GlialCAM activates the slow (common) gate, suggesting
that a similar mechanism underlies the activation of CLC-2. (Supported by
Compagnia San Paolo and Telethon Italy (grants GGP08064 and GGP12008).)
1) Jeworutzki et al. 2012 Neuron73:951.
2) Chen 1998 JGP 112:715.
3) Pusch et al. 1997 JGP 109:105.
4) Lin et al. 1999 JGP 114:1.
3229-Pos Board B384
Kidney CLC-K Chloride Channels Show Differential Pharmacological
Profiles Depending on the Heterologous Expression System
Antonella Liantonio1, Paola Imbrici1, Gianluca Gramegna1,
Antonella Gradogna2, Giovanni Zifarelli2, Antonio Laghezza1,
Giuseppe Fracchiolla1, Giuseppe Carbonara1, Fulvio Loiodice1,
Michael Pusch2, Diana Conte Camerino1.
1Department of Pharmacy, University of Bari, Bari, Italy, 2Istituto di
Biofisica, Consiglio Nazionale delle Ricerche, Genova, Italy.
The human chloride channels CLC-Ka and CLC-Kb play a pivotal role in
kidney by controlling chloride and water absorption. Both channels require
barttin as an accessory subunit for full activity. Mutations in CLC-Kb and
barttin genes lead to severe renal salt loss and CLC-K polymorphisms are
associated with hypertension. Therefore, novel therapeutic approaches target-
ing CLC-K/barttin might be helpful in treating these diseases. We have recently
identified relevant molecular determinants that distinguish CLC-K activators
from blockers using the X.laevis oocyte expression system. We recognized
niflumic acid (NFA) as a powerful activator and phenyl-benzofuran carboxylic
acid analogs as potent inhibitors. Here, by using these molecules as lead com-
pounds and the whole cell configuration of the patch-clamp technique, we ex-
plored the pharmacological profile of CLC-K/barttin expressed in mammalian
HEK-293 cells. Similarly to what observed in amphibian oocytes, benzofuran
derivatives resulted as efficacious blockers of CLC-Ka mediated currents. A
rational drug design allowed us also to ameliorate drug potency, finally identi-fying a newly synthesized benzofuran derivative (SRA-36) with an inhibitory
affinity of 4 mM. Surprisingly, NFA failed to increase CLC-Ka currents, pro-
ducing only an inhibitory effect in the 1-1000 mM range. In order to gain insight
into this relevant difference between the two expression systems, we are cur-
rently evaluating the NFA effect on mutants of CLC-Ka that drastically affect
NFA potentiation in oocytes. Besides identifying new therapeutic drugs, our re-
sults could shed light on structural determinants of CLC-Ks channels activity.
(MIUR- COFIN-2009; Telethon GGP08064, GGP10101, GGP12008).
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Myotonia Congenita is a genetic disease that displays the symptom of muscle
stiffness and impaired muscle relaxation caused by hyperexcitability of the
plasma membrane. There are two types of Myotonia Congenita; Autosomal
dominant Myotonia Congenital (Thomsen’s disease) and autosomal recessive
generalized Myotonia (Becker’s myotonia) are caused by mutations in the skel-
etal muscle chloride channel, ClC-1.
ClC-1, the member of a large family of anion channels, is voltage-gated chlo-
ride channel. It is abundantly expressed in human skeletal muscle. In skeletal
muscle, the voltage-gated chloride channels contribute to stabilize the resting
membrane potential and control electrical excitability. ClC-1 channels contain
double-barreled structure which consists of two identical protopores. Each pore
is voltage dependent and functions independently.
When mutations in the gene for ClC-1 underlie Myotonia Congenita, it can af-
fect normal function of the channel and damage the specialized property of in-
dependently working double pores. Since Mytonia Congenital was first
diagnosed, a number of mutations widely displayed in the protein have been
revealed so far. Here, nine mutants (p.M128I, p.S189C, p.M373L, p.P480S,
p.G523D, p.M609K, p.T310M, p.R317X, p.R47W, A298T and p.G355R)
from Korean patients who suffer from Myotonia Congenita were reported
in 2009. We studied the functional changes of each mutant by using patch
clamp method. We observed remarkably reduced chloride conductance from
most of mutants. Mutants, p.M128I, and p.G523D showed steady-opened cur-
rent pattern compared to WT. Furthermore, open probability of mutants was
slightly or markedly altered and this clearly indicates the modification of
pore property.
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Ca2þ-activated Cl channels (CaCCs) play numerous physiological roles rang-
ing from electrolyte secretion in epithelia and glands, to muscle contraction, ol-
factory transduction and nociception. Despite their physiological importance
the molecular identity of these proteins remained elusive until recent work
showed that TMEM16A and B, two members of the TMEM16 family of mem-
brane proteins, are critical components of CaCCs. Heterologous expression of
these two genes in oocytes and cells results in currents closely resembling na-
tive CaCCs. It is however unknown whether these proteins alone are necessary
and sufficient to form functional Ca2þ activated Cl channels, or whether as-
sociation to other subunits is required. For example, neither TMEM16A nor
B bear any conventional Ca2þ binding motifs and studies suggest that associ-
ation of a TMEM16A isoform with Calmodulin is required for Ca2þ sensitivity.
To investigate whether TMEM16A alone forms functional CaCCs or if associ-
ation to other partner proteins is required we expressed, purified and reconsti-
tuted TMEM16A in proteoliposomes. We found that purified TMEM16A
mediates Ca2þ dependent Cl fluxes with an apparent Km of ~300 nM, a value
comparable to that measured in patch clamp experiments. Channel opening is
also promoted by the application of high positive voltages, consistent with elec-
trophysiological measurements. Channel activity is diminished by CaCC inhib-
itors such as Niflumic Acid, NPPB, NPA and DIDS with K1/2’s comparable to
those measured for native and heterologous CaCCs. Mutating two conserved
glutamates in the TM5-6 intracellular loops abolishes Ca2þ sensitivity of the
fluxes, in a manner similar to what was reported for heterologously expressed
TMEM16A.
In conclusion, our results demonstrate that the purified TMEM16A protein re-
capitulates all the fundamental biophysical and pharmacological properties of
native and heterologously expressed CaCC currents indicating that association
with other partner proteins is not strictly required for function.
